The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Photodynamic therapy in oncology
Abstract
Photodynamic therapy (PDT) is a cancer treatment modality that is based on the administration of a photosensitiser, which is retained in tumour tissues more than in normal tissues, followed by illumination of the tumour with visible light in a wavelength range matching the absorption spectrum of the photosensitiser. The photosensitiser absorbs light energy and induces the production of reactive oxygen species in the tumour environment, generating a cascade of events that kills the tumour cells. The first generation photosensitiser, Photofrin (porfirmer sodium), has been approved for oesophageal and lung cancer in the US and has been under investigation for other malignant and non-malignant diseases. Sub-optimal light penetration at the treatment absorption peak of Photofrin and prolonged skin photosensitivity in patients are limiting factors for this preparation. Several new photosensitisers have improved properties, especially absorption of longer wavelength light which penetrates deeper into tissue and faster clearance from normal tissue. This paper reviews the current use of first- and second-generation photosensitisers in oncology. The use of PDT in oncology has been restricted to certain cancer indications and has not yet become an integral part of cancer treatment in general. The main advantage of PDT is that the treatment can be repeated multiple times safely, without producing immunosuppressive and myelosuppressive effects and can be administered even after surgery, chemotherapy or radiotherapy. The current work on new photosensitisers and light delivery equipment will address some of the present shortcomings of PDT. Much has been learned in recent years about the mechanisms of cellular and tissue responses to PDT and protocols designed to capitalise on this knowledge showed lead to additional improvements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition of type I and type II photosensitized oxidation
Foote, C. S. (1991) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1991.tb02071.x · Cited by 1,248
5-Aminolevulinic Acid-Based Photodynamic Therapy: Principles and Experimental Research
Peng, Q., Berg, K., Moan, J., Kongshaug, M., & Nesland, J. M. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb08549.x · Cited by 615
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy
Loh, C., MacRobert, A., Bedwell, J., Regula, J., Krasner, N., & Bown, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.284 · Cited by 263
Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid
Grant, W. E., MacRobert, A., Bown, S. G., Hopper, C., & Speight, P. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91347-o · Cited by 263
Cited by
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions
Correia, J. H., Rodrigues, J. A., Pimenta, S., Dong, T., & Yang, Z. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091332 · Cited by 1,266
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
A Review of Progress in Clinical Photodynamic Therapy
Huang, Z. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400308 · Cited by 908
Oncologic photodynamic therapy photosensitizers: A clinical review
Allison, R. R., & Sibata, C. H. (2010) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2010.02.001 · Cited by 836
Self-citation
Metadata
- Authors
- Kinsella, T. J., Colussi, V. C., Oleinick, N. L., & Sibata, C. H.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2001-06
- Volume
- 2
- Issue
- 6
- Pages
- 917-927
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W1967585504
- Cited by
- 212
- References
- 4
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Photodynamic therapy in oncology. https://app.cochat.ai/papers/10.1517/14656566.2.6.917
- The paper
- Kinsella, T. J., Colussi, V. C., Oleinick, N. L., & Sibata, C. H. (2001). Photodynamic therapy in oncology. Expert Opinion on Pharmacotherapy. https://doi.org/10.1517/14656566.2.6.917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.